CASI PHARMACEUTICALS, INC. Proceeds from Lines of Credit
CASI PHARMACEUTICALS, INC. (CASIF) reported Proceeds from Lines of Credit of $1.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-05-15
| Period end | Proceeds from Lines of Credit 12 month |
|---|---|
| 2025-12-31 | $1.00M 20-F · filed 2026-05-15 |
| 2022-12-31 | $4.00M 20-F · filed 2025-03-31 |
| 2021-12-31 | $709.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $783.00K 20-F · filed 2023-04-26 |